1 / 19

Hypofractionation in breast cancer

Hypofractionation in breast cancer . Yadav BS , Sharma SC Assistant Professor, Dept. of Radiotherapy, PGIMER, Chandigarh. Introduction. Breast cancer is as sensitive to fraction size as the normal tissues of the breast and underlying rib cage

temira
Download Presentation

Hypofractionation in breast cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hypofractionation in breast cancer Yadav BS, Sharma SC Assistant Professor, Dept. of Radiotherapy, PGIMER, Chandigarh

  2. Introduction • Breast cancer is as sensitive to fraction size as the normal tissues of the breast and underlying rib cage • Hypofractionatedradiotherapy is an established treatment in patients with breast cancer.

  3. Aim To see impact of hypofractionated radiotherapy in breast cancer patients. Cosmetic outcome Locoregional recurrence Disease free survival Overall survival

  4. Materials and methods Duration: Jan 1987 to Dec 2007 Analysis: Retrospective Patient No: 2756 Mean age: 49 years Variables: Age, menopausal status, tumour stage, histology, grade, DRP, ECE, LVI, ER/PR & HER-2 status Treatment:Radiotherapy, chemotherapy & hormones Median FU: 64 months

  5. Age Menopausal status

  6. Surgery • TM+AC: 2139(83.5) • BCS: 420(16.5) • Median No. of nodes: 10:11

  7. Pathological

  8. Nodal status 44%

  9. Radiotherapy PMRT CW 35Gy/15#/3wks SCF 40Gy/15#/3wks Intact Breast 40Gy/16#/3wks Machine: Cobalt/Linac Fields: Tangential SCF

  10. Systemic Treatment

  11. Results

  12. LRR

  13. Distant metastases

  14. Cosmesis

  15. LRRFS 93% RT p<0.001 70% No RT

  16. Overall survival 86% RT 76% No RT p<0.001

  17. Dose & fractionation UK Chd

  18. Conclusion • Hypofractionation reduces treatment time to half while maintaining cosmesis and control rates equal to conventional fractionation. • It will help the radiation centers worldwide to meet the growing need for radiation in breast cancer, particularly in developing countries where resources are limited.

More Related